Redhill Capital

Guangna Development is a producer of micro-nano optics technology designed to improve traditional geometric optical display solutions.

Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.

Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.

Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.

Xianwei Medical is a manufacturer of ophthalmic surgical robots. It focuses on the field of ophthalmic surgical robots, promoting the product finalization and inspection of the third-generation ophthalmic surgical robots while also starting the medical treatment of other product pipelines under research, such as dry eye treatment equipment.

ZD MedTech, also known as Zhuo Dao Medical, specializes in the development of rehabilitation robots and intelligent rehabilitation solutions tailored to the clinical needs of Chinese medicine and its patients. The company boasts a domestic research and development team focused on creating advanced robotic assistive technology that enhances rehabilitation processes. Its offerings include high-end rehabilitation robots and exoskeleton training devices designed to facilitate upper limb recovery. By integrating rich training modes and effective human-computer interaction within its intelligent rehabilitation management system, ZD MedTech aims to improve patient outcomes and expedite rehabilitation treatments. Through ongoing innovation and adaptation to the evolving landscape of rehabilitation medicine, the company is committed to advancing the field and supporting the recovery journey of patients.

Huawei Hengyuan is a biomedical technology company dedicated to the preparation of Sertoli cells (with immune immunity) in vitro using cell reprogramming technology, mainly for: autoimmune diseases (such as rheumatoid arthritis); reproductive adjuvant therapy; human body Chronic diseases (such as Parkinson's); organ/tissue colonization (such as skin allograft).

Precision Autoimmune Therapeutics is a clinical-stage innovative drug development company focused on precision therapeutics for patients with autoimmune and inflammatory diseases.

Metanovas Biotech specializes in the development of nutraceutical and cosmeceutical products utilizing advanced AI technology. The company offers a diverse product pipeline that includes pharmaceuticals, nutritional supplements, functional foods, and cosmetics, aimed at enhancing health and wellness for consumers. Metanovas employs an AI-enabled platform for drug and disease discovery, leveraging machine learning to identify novel disease targets, screen potential drugs, and optimize existing medications for new uses. This innovative approach allows for a more efficient generation of insights and the discovery of effective treatments, fundamentally transforming the intersection of science and artificial intelligence in health product development.

SensView is a company focused on the development and production of solid-state imaging chips and detector modules. Its primary offerings include CMOS flat panel detectors, X-ray detectors like CT detectors and photon counting detectors, as well as other imaging solutions based on monocrystalline silicon technology. These products serve a range of industrial applications, highlighting SensView's commitment to innovation in imaging technology.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

Lecheng Cloud Service is a cloud SaaS insurance platform that provides internet and online insurance service plans.

Xinji Pharmaceuticals is mainly engaged in the R&D of new drug preparations and drug release systems. The company is especially involved in the application and promotion of drug-controlled release, sustained release, and targeted drug release technologies in the industrialization of biomedicine.

Manteia Technology, founded in 2017 and based in Xiamen, China, specializes in radiology systems with a focus on cancer treatment. The company integrates deep learning and data technology to develop advanced solutions for tumor radiotherapy, including automatic target volume delineation software, dose calculation and evaluation systems, and intelligent adaptive radiotherapy systems. Manteia employs a skilled research and development team, comprised of approximately 50 engineers and algorithms, with a significant portion having medical backgrounds. The firm has garnered recognition as a "Double Hundred Talents" enterprise by the Xiamen Municipal Government and has received strategic investments from Fosun Group and Danlu Capital. Manteia holds 26 software copyrights, along with multiple patents, and its core personnel have published over 170 scientific papers in the field of radiotherapy. Additionally, the company has a wholly-owned subsidiary in the United States, further expanding its reach in the healthcare sector.

SensView is a company focused on the development and production of solid-state imaging chips and detector modules. Its primary offerings include CMOS flat panel detectors, X-ray detectors like CT detectors and photon counting detectors, as well as other imaging solutions based on monocrystalline silicon technology. These products serve a range of industrial applications, highlighting SensView's commitment to innovation in imaging technology.

Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.

Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.

Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.

Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.

Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.

Vistel is a technology company founded in 2016 by Sun Yuhui and Ding Dayong, specializing in the application of artificial intelligence in the medical field. The firm focuses on developing AI-driven ophthalmic medical imaging technology designed to enhance the diagnosis of eye diseases. By utilizing advanced diagnostic systems that incorporate computer vision processing and image annotation, Vistel aims to provide medical practitioners with innovative tools for the digital analysis and management of patients' eye conditions.

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

GenAssist Therapeutics is a biotechnology company founded in July 2020 that specializes in developing gene therapy drugs using advanced base editing technology. The company focuses on addressing genetic diseases, particularly neuromuscular disorders such as Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA), for which effective treatments are currently lacking. By employing Targeted AID-based Mutagenesis (TAM) technology, GenAssist aims to precisely repair disease-causing genes in situ, offering the potential for permanent cures. The company possesses global intellectual property rights for its innovative approach, reflecting its commitment to advancing gene editing therapies across a range of genetic conditions.

Cofoe is a medical device company that focuses on developing and providing a range of home medical equipment and health products. The company offers comprehensive solutions in healthcare monitoring, rehabilitation aids, respiratory support, and traditional Chinese medicine. Cofoe operates several brands, including Jianer Hearing, which provides extensive hearing solutions; Good Nurse Medical Devices, known for its omnichannel retail and management of medical devices; Keyuan Medica, which focuses on creating a streamlined medical device supply chain; and Youngleda, which specializes in portable oxygen generators and related consumables. Through its diverse offerings, Cofoe aims to enhance health and wellness for its customers.

PandaMed, officially known as Changzhou Zhishan Medical Technology Co., Ltd., was established in May 2017 by a team of domestic and international medical experts. Located in the West Taihu Hi-Tech Industrial Park in Changzhou, the company specializes in the research, development, and industrialization of non-invasive medical devices, primarily targeting diabetes and weight management. PandaMed is recognized as the first high-tech company in China dedicated to these areas. Its offerings include an intragastric balloon system and comprehensive health management services, aimed at providing effective, non-invasive solutions for obese patients and addressing chronic diseases. The company also boasts a state-of-the-art research and development center in Shanghai, further enhancing its capabilities in medical technology innovation.

Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.

Mingyitang Hospital is a traditional medicine clinic operator.

Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.